(Presolicitation Notice) Intent to Sole Source - BioRad Antibodies
ID: PR-95570 • Type: Presolicitation
• Match:
90%
Opportunity Assistant
Loading
Overview
Response Deadline
Aug. 1, 2026, 1:00 a.m. EDT
Due in 14 Days
Posted
July 17, 2026, 12:59 p.m. EDT
Set Aside
None
Place of Performance
Atlanta, GA
United States
Source
Current SBA Size Standard
1250 Employees
Est. Level of Competition
Sole Source
Est. Value Range
Experimental
$10,000 - $75,000
(AI estimate)
Odds of Award
21%
On 7/17/26 Centers for Disease Control and Prevention issued Presolicitation PR-95570 for (Presolicitation Notice) Intent to Sole Source - BioRad Antibodies due 8/1/26.
The opportunity was issued full & open with NAICS 325414 and PSC 6640.
Primary Contact
Documents
Posted documents for Presolicitation PR-95570
Opportunity Assistant
AI Analysis
AI Generate
Incumbent or Similar Awards
Potential Bidders and Partners
Awardees that have won contracts similar to Presolicitation PR-95570
Similar Active Opportunities
Open contract opportunities similar to Presolicitation PR-95570
Experts for (Presolicitation Notice) Intent to Sole Source - BioRad Antibodies
Recommended subject matter experts available for hire
Additional Details
Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > CENTERS FOR DISEASE CONTROL AND PREVENTION > CDC OFFICE OF ACQUISITION SERVICES
FPDS Organization Code
7523-00254
Source Organization Code
100188028
Last Updated
July 17, 2026
Last Updated By
ahr0@cdc.gov
Archive Date
Aug. 1, 2026